Pro-inflammatory and vasoconstricting prostanoid PGF2α causes no headache in man

Cephalalgia

Volumn 31, Issue 15, 2011, Pages 1532-1541

  Antonova, Maria ^a   Wienecke, Troels ^a   Olesen, Jes ^a   Ashina, Messoud ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

headache; healthy volunteers; Prostaglandin F2 alpha; prostaglandins; vasoconstriction; vasodilatation

Indexed keywords

PLACEBO; PROSTAGLANDIN F2 ALPHA;

ADULT; ARTERY DIAMETER; ARTICLE; BRAIN BLOOD FLOW; CONTROLLED STUDY; CROSSOVER PROCEDURE; EXPERIMENTAL MODEL; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; MALE; MIDDLE CEREBRAL ARTERY; NORMAL HUMAN; PAIN ASSESSMENT; RADIAL ARTERY; RATING SCALE; SUPERFICIAL TEMPORAL ARTERY; VASODILATATION; VERBAL RATING SCALE;

ADULT; ARTERIES; CROSS-OVER STUDIES; DINOPROST; FEMALE; HEADACHE; HUMANS; INFLAMMATION MEDIATORS; MALE; VASOCONSTRICTOR AGENTS; YOUNG ADULT;

EID: 81855218978     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102411423314     Document Type: Article

References (59)

1. Tfelt-Hansen P. Triptans vs other drugs for acute migraine. Are there differences in efficacy? A comment. Headache. 2008 ; 48: 601-605 (Pubitemid 351467624)
2. Evers S. Treatment of migraine with prophylactic drugs. Expert Opin Pharmacother. 2008 ; 9: 2565-2573
3. Goadsby PJ. Pathophysiology of migraine. Neurol Clin. 2009 ; 27: 335-360
4. Ho TW, Edvinsson L, Goadsby PJ. CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol. 2010 ; 6: 573-582
5. Ramadan NM, Skljarevski V, Phebus LA, Johnson KW. 5-HT1F receptor agonists in acute migraine treatment: a hypothesis. Cephalalgia. 2003 ; 23: 776-785 (Pubitemid 37255418)
6. Asghar MS, Hansen AE, Amin FM, et al. Evidence for a vascular factor in migraine. Ann Neurol. 2011 ; 69: 635-645
7. Schytz HW, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M. PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain. 2009 ; 132: 16-25
8. Wienecke T, Olesen J, Ashina M. Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs. Cephalalgia. 2010 ; 30: 179-190
9. Lindholt M, Petersen KA, Tvedskov JF, Iversen HK, Olesen J, Tfelt-Hansen P. Lack of effect of norepinephrine on cranial haemodynamics and headache in healthy volunteers. Cephalalgia. 2009 ; 29: 384-387
10. Wienecke T, Olesen J, Oturai PS, Ashina M. Prostacyclin (epoprostenol) induces headache in healthy subjects. Pain. 2008 ; 139: 106-116
11. Wienecke T, Olesen J, Oturai PS, Ashina M. Prostaglandin E2(PGE2) induces headache in healthy subjects. Cephalalgia. 2009 ; 29: 509-519
12. Wienecke T, Olesen J, Ashina M. Discrepancy between strong cephalic arterial dilatation and mild headache caused by prostaglandin D2 (PGD2). Cephalalgia. 2011 ; 31: 65-76
13. Hata AN, Breyer RM. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther. 2004 ; 103: 147-166 (Pubitemid 39209041)
14. Ito S, Okuda-Ashitaka E, Minami T. Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin. Neurosci Res. 2001 ; 41: 299-332 (Pubitemid 33733750)
15. Vysniauskiene I, Allemann R, Flammer J, Haefliger IO. Vasoactive responses of U46619, PGF2alpha, latanoprost, and travoprost in isolated porcine ciliary arteries. Invest Ophthalmol Vis Sci. 2006 ; 47: 295-298 (Pubitemid 46780827)
16. Uchiyama M, Sakai K. Increased main urinary metabolite of prostaglandin F2 alpha excretion in childhood migraine. Arch Dis Child. 1988 ; 63: 342-342
17. Durham PL, Vause CV, Derosier F, McDonald S, Cady R, Martin V. Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea. Headache. 2010 ; 50: 844-851
18. Forsogsperson.dk, Trial volunteers, http://www.forsogsperson.dk (accessed August 2011).
19. Randomization.com, Randomization plan generators, http://www. randomization.com (accessed August 2011).
20. US National Institutes of Health, ClinicalTrials.gov, http://www.clinicaltrials.gov (accessed August 2011).
21. Iversen HK, Olesen J, Tfelt-Hansen P. Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain. 1989 ; 38: 17-24 (Pubitemid 19184833)
22. Olesen J, Steiner TJ. The International classification of headache disorders, 2nd edn (ICDH-II). J Neurol Neurosurg Psychiatry. 2004 ; 75: 808-811 (Pubitemid 38658498)
23. Thomsen LL, Iversen HK. Experimental and biological variation of three-dimensional transcranial Doppler measurements. J Appl Physiol. 1993 ; 75: 2805-2810 (Pubitemid 24008404)
24. Campbell MJ, Julious SA, Altman DG. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ. 1995 ; 311: 1145-1148
25. Pocock SJ Clinical trials: a practical approach. Chichester and New York: John Wiley and Sons ; 1983 :
26. Markwalder TM, Grolimund P, Seiler RW, Roth F, Aaslid R. Dependency of blood flow velocity in the middle cerebral artery on end-tidal carbon dioxide partial pressure-a transcranial ultrasound Doppler study. J Cereb Blood Flow Metab. 1984 ; 4: 368-372 (Pubitemid 14034628)
27. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ. 1990 ; 300: 230-235 (Pubitemid 20045528)
28. Yoshikawa K, Kita Y, Kishimoto K, Shimizu T. Profiling of eicosanoid production in the rat hippocampus during kainic acid-induced seizure: dual phase regulation and differential involvement of COX-1 and COX-2. J Biol Chem. 2006 ; 281: 14663-14669 (Pubitemid 43855170)
29. Suzuki-Yamamoto T, Toida K, Watanabe K, Ishimura K. Immunocytochemical localization of prostaglandin F synthase II in the rat spinal cord. Brain Res. 2003 ; 969: 27-35 (Pubitemid 36369609)
30. Yoshikawa K, Takei S, Hasegawa-Ishii S, et al. Preferential localization of prostamide/prostaglandin F synthase in myelin sheaths of the central nervous system. Brain Res. 2011 ; 1367: 22-32
31. Muratani T, Nishizawa M, Matsumura S, et al. Functional characterization of prostaglandin F2alpha receptor in the spinal cord for tactile pain (allodynia). J Neurochem. 2003 ; 86: 374-382 (Pubitemid 36842436)
32. Kitanaka J, Hashimoto H, Gotoh M, et al. Expression pattern of messenger RNAs for prostanoid receptors in glial cell cultures. Brain Res. 1996 ; 707: 282-287 (Pubitemid 26056526)
33. Minami T, Uda R, Horiguchi S, Ito S, Hyodo M, Hayaishi O. Allodynia evoked by intrathecal administration of prostaglandin F2 alpha to conscious mice. Pain. 1992 ; 50: 223-229
34. Minami T, Nishihara I, Ito S, Sakamoto K, Hyodo M, Hayaishi O. Nitric oxide mediates allodynia induced by intrathecal administration of prostaglandin E2 or prostaglandin F2 alpha in conscious mice. Pain. 1995 ; 61: 285-290
35. Minami T, Matsumura S, Okuda-Ashitaka E, et al. Characterization of the glutamatergic system for induction and maintenance of allodynia. Brain Res. 2001 ; 895: 178-185 (Pubitemid 32231154)
36. Turnbach ME, Spraggins DS, Randich A. Spinal administration of prostaglandin E(2) or prostaglandin F(2alpha) primarily produces mechanical hyperalgesia that is mediated by nociceptive specific spinal dorsal horn neurons. Pain. 2002 ; 97: 33-45 (Pubitemid 34603307)
37. Kunori S, Matsumura S, Mabuchi T, et al. Involvement of prostaglandin F 2 alpha receptor in ATP-induced mechanical allodynia. Neuroscience. 2009 ; 163: 362-371
38. Bito LZ, Wallenstein MC. Transport of prostaglandins across the blood-brain and blood-aqueous barriers and the physiological significance of these absorptive transport processes. Exp Eye Res. 1977 ; 25 (Suppl). 229-243 (Pubitemid 8205036)
39. Lin CR, Amaya F, Barrett L, et al. Prostaglandin E2 receptor EP4 contributes to inflammatory pain hypersensitivity. J Pharmacol Exp Ther. 2006 ; 319: 1096-1103
40. Southall MD, Vasko MR. Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E2-induced cAMP production and sensitization of sensory neurons. J Biol Chem. 2001 ; 276: 16083-16091
41. Okuda-Ashitaka E, Minami T, Matsumura S, et al. The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E2-induced allodynia, tactile pain associated with nerve injury. Eur J Neurosci. 2006 ; 23: 995-1004 (Pubitemid 43344694)
42. Strassman AM, Raymond SA, Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature. 1996 ; 384: 560-564 (Pubitemid 26415932)
43. Zhang XC, Strassman AM, Burstein R, Levy D. Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators. J Pharmacol Exp Ther. 2007 ; 322: 806-812 (Pubitemid 47105821)
44. Ayajiki K, Fujioka H, Noda K, Okamura T, Toda N. Modifications by sumatriptan and acetylcholine of nitric oxide-mediated neurogenic dilatation in dog cerebral arteries. Eur J Pharmacol. 2001 ; 420: 67-72 (Pubitemid 32539096)
45. Toda N, Onoue H. Prostaglandin F2 alpha-induced contraction in isolated dog cerebral, coronary and mesenteric arteries soaked in excess potassium. Jpn J Pharmacol. 1988 ; 47: 204-207
46. Sipkema P, van der Linden PJ, Fanton J, Latham RD. Responses to mechanical stimuli of isolated basilar and femoral arteries of the Rhesus monkey are different. Heart Vessels. 1996 ; 11: 18-26 (Pubitemid 26102347)
47. Wendling WW, Harakal C. Effects of prostaglandin F2 alpha and thromboxane A2 analogue on bovine cerebral arterial tone and calcium fluxes. Stroke. 1991 ; 22: 66-72
48. Bevan R, Dodge J, Nichols P, et al. Responsiveness of human infant cerebral arteries to sympathetic nerve stimulation and vasoactive agents. Pediatr Res. 1998 ; 44: 730-739 (Pubitemid 28519202)
49. Wallerstedt SM, Reinstrup P, Uski T, Bodelsson M. Effects of propofol on isolated human pial arteries. Acta Anaesthesiol Scand. 1999 ; 43: 1065-1068 (Pubitemid 29529823)
50. White LR, Leseth KH, Möller S, et al. Interleukin-1beta potentiates endothelin ET(B) receptor-mediated contraction in cultured segments of human temporal artery. Regul Pept. 1999 ; 81: 89-95 (Pubitemid 29248805)
51. He GW, Yang CQ. Inhibition of vasoconstriction by the thromboxane A2 antagonist GR32191B in the human radial artery. Br J Clin Pharmacol. 1999 ; 48: 207-215
52. Ryszawa N, Rudziński P, Piatek J, et al. Different reactivity of the proximal and distal segments of the radial artery to vasoconstrictors in patients undergoing coronary artery bypass grafting. Kardiol Pol. 2007 ; 65: 1313-1319 (Pubitemid 350164186)
53. Murray MA, Faraci FM, Heistad DD. Signal transduction pathways in constriction of the basilar artery in vivo. Hypertension. 1992 ; 19: 739-742
54. Kapp JP, Robertson JT, White RP. Spasmogenic qualities of prostaglandin F2alpha in the cat. J Neurosurg. 1976 ; 44: 173-175
55. Rosenblum WI. Constriction of pial arterioles produced by prostaglandin F2alpha. Stroke. 1975 ; 6: 293-297
56. Wahl M, Schilling L, Whalley ET. Cerebrovascular effects of prostanoids. In-situ studies in pial arteries of the cat. Naunyn Schmiedebergs Arch Pharmacol. 1989 ; 340: 314-320 (Pubitemid 19240123)
57. Ellis EF, Wei EP, Cockrell CS, Choi S, Kontos HA. The effect of PGF2 alpha on in vivo cerebral arteriolar diameter in cats and rats. Prostaglandins. 1983 ; 26: 917-923 (Pubitemid 14165831)
58. Yu Y, Lucitt MB, Stubbe J, et al. Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis. Proc Natl Acad Sci U S A. 2009 ; 106: 7985-7990
59. Abera AB, Sales KJ, Catalano RD, Katz AA, Jabbour HN. EP2 receptor mediated cAMP release is augmented by PGF 2 alpha activation of the FP receptor via the calcium-calmodulin pathway. Cell Signal. 2010 ; 22: 71-79